Markets:

Overview

News

Currencies

International

Treasuries

GSK plc American Depositary Shares (Each representing two Ordinary Shares) (NY:GSK)

52.42 -0.39 (-0.74%)

Official Closing Price Updated: 7:00 PM EDT, Jun 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about GSK plc American Depositary Shares (Each representing two Ordinary Shares)

< Previous 1 2

...

14 15 16 17 18 19 20 21 22

...

45 46 Next >

Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024 ↗

January 05, 2024

Between buyouts, obesity drugs and neuroscience progress, biotech stocks stand to gain.

Via Investor's Business Daily

Sleeper Hits: 3 Unexpected Stocks Poised for a Breakout in 2024 ↗

January 05, 2024

Many stocks emerge from Wall Street's doghouse relatively quickly. Here are three names that could become surprise breakout stocks for 2024.

Via InvestorPlace

More Than 140 Drug Brands Will Have Their Prices Hiked Heading Into 2024 ↗

January 04, 2024

More than 140 brands of drugs are going to see their prices hiked heading into the new year

Via Talk Markets

Dell To Rally Over 20%? Here Are 10 Top Analyst Forecasts For Wednesday ↗

January 03, 2024

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

GSK's Jemperli Cancer Drug Hits Primary Goal In Endometrial Cancer Study ↗

December 18, 2023

GSK plc (NYSE: GSK)

Via Benzinga

Looking Into GSK's Recent Short Interest ↗

December 18, 2023

Via Benzinga

Verona Pharma's Promising COPD Treatment Puts It in GSK's Acquisition Crosshairs, Analysts Predict Big Moves ↗

December 29, 2023

In recent statements to the Financial Times and The Sunday Times, GSK plc (NYSE: GSK) Chief Commercial Officer Luke Miels revealed the company's intent to pursue acquisitions within the $2 billion...

Via Benzinga

Expensive Drugs For Americans In 2024? Drugmakers Including Pfizer, Sanofi Mull Price Increase In January ↗

December 29, 2023

Just as large pharma companies prepare a showdown with Medicare's newfound power to negotiate down drug prices, several major drug companies are reportedly gearing up to implement price increases on...

Via Benzinga

Pharmaceutical Giants Brace for Showdown as Medicare Drug Price Negotiations Are Poised For 2024 ↗

December 28, 2023

2024 will mark a pivotal moment for the healthcare industry, particularly in drug pricing negotiations.

Via Benzinga

3 Growth at a Reasonable Price (GARP) Stocks for Balanced Growth ↗

December 22, 2023

GARP stocks are less likely to plunge than growth stocks with high valuations and more likely to generate strong growth than value stocks.

Via InvestorPlace

Price Over Earnings Overview: GSK ↗

November 22, 2023

Via Benzinga

Looking Into GSK's Recent Short Interest ↗

November 20, 2023

Via Benzinga

Merck's Chronic Cough Treatment Candidate Receives Second Time FDA Rejection ↗

December 21, 2023

The FDA issued a Complete Response Letter (CRL) regarding Merck & Co Inc's (NYSE: MRK) New Drug Application (NDA) for gefapixant under development for the treatment of refractory chronic cough (RCC) or...

Via Benzinga

COVAX Global Initiative For COVID-19 Vaccines Comes To An End Amid Shift To Regular Programs ↗

December 20, 2023

COVAX, the multilateral mechanism for equitable global access to COVID-19 vaccines launched in 2020, will close on 31 December 2023.&n

Via Benzinga

GSK Awards $1M in COiMMUNITY Initiative Grants to Support Adult Immunization and Health Equity

December 12, 2023

From GSK plc

Via Business Wire

3 cheap 'stock'-ing stuffers Wall Street is bullish on

December 07, 2023

These three companies have Wall Street feeling bullish and are trading under $10, making them ideal ‘stock'-ing stuffers for hard to shop for traders.

Via MarketBeat

Topics Stocks

Why Is Genetic Medicines-Focused Wave Life Sciences Stock Trading Lower Today? ↗

December 07, 2023

Wave Life Sciences Ltd (NASDAQ: WVE) has priced its previously announced underwritten public offering of 20 million shares at $5.00 per share with approximately

Via Benzinga

These biotechs targeting multiple neurodegenerative diseases

December 01, 2023

A growing number of up-and-coming biotech firms are demonstrating the value of expanding a drug's total addressable market.

Via MarketBeat

Competition and Optimism: GSK's CEO Walmsley Foresees Growth Despite Competition In RSV Vaccine Market ↗

November 30, 2023

Emma Walmsley, the Chief Executive Officer of GSK plc (NYSE: GSK), expressed confidence in its respiratory syncytial virus (RSV) vaccine, Arexvy, anticipating sales to surpass £1 billio

Via Benzinga

3 Stocks to Sell for Tax Losses Before the New Year ↗

November 28, 2023

While no one wants to lose in the market, you can be productive with the red ink through stocks to sell for tax losses.

Via InvestorPlace

3 Great Foreign Companies to Invest in Right Now ↗

November 27, 2023

The world is a big place, and many great companies are based outside our U.S. borders.

Via The Motley Fool

GSK Frames A Comeback For Its Multiple Myeloma Drug Following Encouraging Phase 3 Data ↗

November 27, 2023

GSK plc (NYSE: GSK) announced headline

Via Benzinga

Merck's Latest Drug For Chronic Cough Faces FDA Pushback ↗

November 18, 2023

A panel of advisors to the Food and Drug Administration (FDA) reportedly expressed concerns about the efficacy of Merck & Company, Inc.'s (NYSE:

Via Benzinga

Senator's Bearish Tesla Bet Under Scrutiny As He Buys Put Options Ahead Of Elon Musk-Led Company's Q3 Results That Set Stock Slide In Motion ↗

November 17, 2023

Sen. Tommy Tuberville bought 3 tranches of put options to sell Tesla shares at $190 a day ahead of Q3 results that set in motion a stock slump.

Via Benzinga

Diversifying Your Portfolio With Plant-Based Options ↗

November 16, 2023

Investors see profit potential in the plant-based market due to rising consumer demand, ESG focus, and the growth of vegan products in various industries, including pharmaceuticals. However, market...

Via Talk Markets

Major Buyout Firms Eye Sanofi's Consumer Health Division Spinoff Valued Over $20B ↗

November 16, 2023

Sanofi SA (NYSE: SNY) has reportedly initiated talks with Rothschild & Co. to explore the possibility of spinning off its consumer health division, which could potentially value the business at over...

Via Benzinga

Current Analysis: GSK Plc ↗

November 16, 2023

In the pharmaceutical industry, GSK PLC ranks as one of the largest companies by total sales.

Via Talk Markets

Acuitas Challenges CureVac in Legal Tussle Over COVID-19 Vaccine Technology ↗

November 15, 2023

Biotech company Acuitas Therapeutics has filed a lawsuit in Virginia federal court against Germany-based CureVac SE (NASDAQ: CVAC), accusing it of failing to credit Acuitas on patents related to...

Via Benzinga

Topics Intellectual Property Lawsuit

European Drug Regulator Recommends Approval Of GSK's Bone Marrow Cancer Med ↗

November 13, 2023

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency adopted a posi

Via Benzinga

GSK and Queer Eye’s Thom Filicia Partner on Blood Cancer Awareness Initiative

November 13, 2023

From GSK plc

Via Business Wire

< Previous 1 2

...

14 15 16 17 18 19 20 21 22

...

45 46 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

GSK plc American Depositary Shares (Each representing two Ordinary Shares) (NY:GSK)

All News about GSK plc American Depositary Shares (Each representing two Ordinary Shares)

Starting at $3.75/week.

Subscribe Today